We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$21M
Cap. Flow
+$284M
Cap. Flow %
244.1%
Top 10 Hldgs %
42.12%
Holding
462
New
171
Increased
79
Reduced
68
Closed
122

Sector Composition

1 Healthcare 41.4%
2 Technology 6.27%
3 Consumer Staples 4.14%
4 Consumer Discretionary 2.26%
5 Materials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXLT
451
PUT
DELISTED
BAXALTA INC COM STK (DE)
BXLT
-62,000
Closed -$85K
SNDK
452
CALL
DELISTED
SANDISK CORP
SNDK
-7,100
Closed -$41K
SNDK
453
PUT
DELISTED
SANDISK CORP
SNDK
-22,000
Closed -$16K
ADT
454
DELISTED
ADT Corp
ADT
-19,541
Closed -$806K
ADT
455
PUT
DELISTED
ADT Corp
ADT
-18,100
Closed -$5K
HOT
456
PUT
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
-15,000
Closed -$2K
LNKD
457
CALL
DELISTED
LinkedIn Corporation
LNKD
-11,400
Closed -$33K
TWC
458
CALL
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-12,400
Closed -$172K
TWC
459
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-4,151
Closed -$849K
TWC
460
PUT
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-21,800
Closed -$15K
TIVO
461
CALL
DELISTED
TIVO INC
TIVO
-24,000
Closed -$16K
ANAC
462
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
-56,100
Closed -$342K

Similar funds

FT Options's Q2 2016 Portfolio in Review

As of Q2 2016, FT Options held 462 positions worth $116M, up 22% from $95.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

FT Options deployed $284M of net new capital in Q2 2016, opening 171 new positions and adding to 79 existing holdings. Its largest new stake was Bristol-Myers Squibb: 35,075 shares worth $2.58M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.

  • FT Options's largest Q2 2016 buy was Bristol-Myers Squibb: 35,075 shares worth $2.58M.
  • FT Options added most to MEDIVATION, INC. in Q2 2016, an estimated $4.59M increase.
  • FT Options's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $2M.
  • FT Options fully exited Baxter International in Q2 2016, selling an estimated $4.11M.
  • FT Options's ten largest holdings make up 42% of its $116M portfolio in Q2 2016.
  • FT Options opened 171 new positions and closed 122 in Q2 2016.
  • FT Options's portfolio value rose 22% quarter-over-quarter to $116M.

Based on FT Options's 13F filing for Q2 2016, filed 12 Aug 2016.